Journal: IBRO Neuroscience Reports

Article Title: TNKS1 mediates the PTEN-PI3K/AKT pathway to regulate glycolysis and proliferation in gliomas

doi: 10.1016/j.ibneur.2026.01.007

Figure Lengend Snippet: Inhibition of TNKS1 expression can suppress cell proliferation in glioma xenografts.HE staining to observe cell morphology in each group (A); immunohistochemistry to detect Ki-67 values in cells from each group (B), with an asterisk (*) indicating a significant difference compared to the TNKS1-siRNA NC group, P < 0.05. Scale bar = 50 μm.

Article Snippet: The primary antibody used was rabbit anti-Ki67 antibody (HA721115, 1:200, HUABIO, USA), which was incubated overnight at 4°C.

Techniques: Inhibition, Expressing, Staining, Immunohistochemistry

Journal: Bioactive Materials

Article Title: Ameliorating post-infarction myocardial fibrosis and cardiac function via ROS-responsive hydrogel-mediated IL-11 antibody delivery

doi: 10.1016/j.bioactmat.2026.01.041

Figure Lengend Snippet: P-T@MAB injection promotes angiomyogenesis. Immunostaining images show TUNEL at 3 days post-injection (A), Ki67 (C), vWF (E), and CD31 (F) expression in heart sections at 4 weeks post-injection. Quantitative analysis of TUNEL (B), Ki67 (D), vWF (G), and CD31 (G) is presented (n = 5). Scale bars: 100 μm. n.s., not significant; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.

Article Snippet: For immunostaining of biomarkers including Ki67 (CST, 9129), CD31 (Abcam, ab222783), vWF (Abcam, ab31630), α-SMA (Abcam, ab7817), Collagen I (CST, 66948), and Collagen III (Abcam, ab6310), samples were incubated overnight at 4 °C with primary antibodies diluted in blocking buffer.

Techniques: Injection, Immunostaining, TUNEL Assay, Expressing